FMNL3 and neoplasm: However, a positive correlation was found for the clinical classification (I-II vs. III-IV; p < 0.001 for FMNL3, membrane E-cadherin, and Vimentin), T (tumour) classification (T1-T2 vs. T3-T4; p < 0.01 for FMNL3, p < 0.05 for membrane E-cadherin and Vimentin), N (metastasis of lymph node) classification (N0-N1 vs. N2-N3; p < 0.05 for FMNL3) and M (distant metastasis) classification (M0 vs. M1; p < 0.05 for FMNL3) (Table 1).